Héctor Aviña

1.2k total citations
5 papers, 138 citations indexed

About

Héctor Aviña is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Héctor Aviña has authored 5 papers receiving a total of 138 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Genetics and 1 paper in Molecular Biology. Recurrent topics in Héctor Aviña's work include HER2/EGFR in Cancer Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Héctor Aviña is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and CAR-T cell therapy research (2 papers). Héctor Aviña collaborates with scholars based in United States, Canada and Chile. Héctor Aviña's co-authors include Josh Snyder, David R. Stover, Fernando Doñate, Karen Morrison, Marisol Belmonte, Aldo Saavedra, Hugo Valdés, Marcos Flores, Zhilan Zeng and Sathish Kumar Ganesan and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and Membranes.

In The Last Decade

Héctor Aviña

5 papers receiving 136 citations

Peers

Héctor Aviña

ONCOL

SURGE

RNMI

WST

MB

Min-Hwan Kim South Korea

Michał Piotr Budzik Poland

Yuchao Fei China

Jinhui Xue China

Craig Dick United Kingdom

Hai Liu China

Yonglong Yang China

Huabin Li China

Nicole Ryabin United States

Roberto Díaz Beveridge Spain

Min-Hwan Kim South Korea

Héctor Aviña

27 ×0.4

ONCOL

40 ×1.1

SURGE

8 ×0.2

RNMI

13 ×0.5

WST

97 ×4.0

MB

Citations per year, relative to Héctor Aviña Héctor Aviña (= 1×) peers Min-Hwan Kim

Countries citing papers authored by Héctor Aviña

Since Specialization

Citations

This map shows the geographic impact of Héctor Aviña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Héctor Aviña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Héctor Aviña more than expected).

Fields of papers citing papers by Héctor Aviña

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Héctor Aviña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Héctor Aviña. The network helps show where Héctor Aviña may publish in the future.

Co-authorship network of co-authors of Héctor Aviña

This figure shows the co-authorship network connecting the top 25 collaborators of Héctor Aviña. A scholar is included among the top collaborators of Héctor Aviña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Héctor Aviña. Héctor Aviña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Valdés, Hugo, et al.. (2021). Reverse Osmosis Concentrate: Physicochemical Characteristics, Environmental Impact, and Technologies. Membranes. 11(10). 753–753. 34 indexed citations

2.

Zhao, Hui, Sathish Kumar Ganesan, Karen Morrison, et al.. (2017). Inhibition of Megakaryocyte Differentiation by Antibody–Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia. Molecular Cancer Therapeutics. 16(9). 1877–1886. 47 indexed citations

3.

Karki, Sher, Héctor Aviña, Ahmed Sawas, et al.. (2017). Abstract 2709: Evaluation of CD37 expression and binding of AGS67E, an antibody-drug conjugate (ADC) against CD37, on white blood cells (WBCs) collected from phase I non-Hodgkin lymphoma (NHL) patients. Cancer Research. 77(13_Supplement). 2709–2709. 1 indexed citations

4.

Doñate, Fernando, Yang Pu, Kendall Morrison, et al.. (2017). Analysis of preclinical and clinical samples after treatment with a CD37 targeting antibody drug conjugate (AGS67E) support a high level of CD37 expression in NHL. Hematological Oncology. 35(S2). 290–291. 1 indexed citations

5.

Morrison, Kendall, Pia M. Challita-Eid, Arthur Raitano, et al.. (2016). Development of ASG-15ME, a Novel Antibody–Drug Conjugate Targeting SLITRK6 , a New Urothelial Cancer Biomarker. Molecular Cancer Therapeutics. 15(6). 1301–1310. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact